Paul F. Lizzul - Net Worth and Insider Trading
Paul F. Lizzul Net Worth
The estimated net worth of Paul F. Lizzul is at least $297,731 dollars as of 2024-11-05. Paul F. Lizzul is the Chief Medical Officer of AnaptysBio Inc and owns about 15,398 shares of AnaptysBio Inc (ANAB) stock worth over $297,720. Paul F. Lizzul is also the Chief Medical Officer of Sienna Biopharmaceuticals Inc and owns about 105,191 shares of Sienna Biopharmaceuticals Inc (SNNAQ) stock worth over $11. Details can be seen in Paul F. Lizzul's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul F. Lizzul has not made any transactions after 2024-09-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul F. Lizzul
Paul F. Lizzul Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul F. Lizzul owns 2 companies in total, including AnaptysBio Inc (ANAB) , and Sienna Biopharmaceuticals Inc (SNNAQ) .
Click here to see the complete history of Paul F. Lizzul’s form 4 insider trades.
Insider Ownership Summary of Paul F. Lizzul
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ANAB | AnaptysBio Inc | 2024-09-23 | Chief Medical Officer |
| SNNAQ | Sienna Biopharmaceuticals Inc | 2019-08-06 | Chief Medical Officer |
Paul F. Lizzul Latest Holdings Summary
Paul F. Lizzul currently owns a total of 2 stocks. Among these stocks, Paul F. Lizzul owns 15,398 shares of AnaptysBio Inc (ANAB) as of September 23, 2024, with a value of $297,720 and a weighting of 100%. Paul F. Lizzul also owns 105,191 shares of Sienna Biopharmaceuticals Inc (SNNAQ) as of August 1, 2017, with a value of $11 and a weighting of 0%.
Latest Holdings of Paul F. Lizzul
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ANAB | AnaptysBio Inc | 2024-09-23 | 15,398 | 19.34 | 297,720 |
| SNNAQ | Sienna Biopharmaceuticals Inc | 2017-08-01 | 105,191 | 0.00 | 11 |
Holding Weightings of Paul F. Lizzul
Paul F. Lizzul Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul F. Lizzul has made a total of 6 transactions in AnaptysBio Inc (ANAB) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in AnaptysBio Inc is the sale of 1,500 shares on September 23, 2024, which brought Paul F. Lizzul around $58,005.
According to the SEC Form 4 filings, Paul F. Lizzul has made a total of 0 transactions in Sienna Biopharmaceuticals Inc (SNNAQ) over the past 5 years. The most-recent trade in Sienna Biopharmaceuticals Inc is the acquisition of 10,000 shares on August 1, 2017, which cost Paul F. Lizzul around $150,000.
Insider Trading History of Paul F. Lizzul
- 1
Paul F. Lizzul Trading Performance
GuruFocus tracks the stock performance after each of Paul F. Lizzul's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul F. Lizzul is -3.77%. GuruFocus also compares Paul F. Lizzul's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul F. Lizzul within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul F. Lizzul's insider trading performs compared to the benchmark.
Performance of Paul F. Lizzul
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 18.66 | | | | | |
| Relative Return to S&P 500(%) | 18.65 | | | | | |
Paul F. Lizzul Ownership Network
Ownership Network List of Paul F. Lizzul
Ownership Network Relation of Paul F. Lizzul
Paul F. Lizzul Owned Company Details
What does AnaptysBio Inc do?
Who are the key executives at AnaptysBio Inc?
Paul F. Lizzul is the Chief Medical Officer of AnaptysBio Inc. Other key executives at AnaptysBio Inc include General Counsel Eric J Loumeau , Chief Financial Officer Dennis Mulroy , and 10 percent owner Ecor1 Capital, Llc .
AnaptysBio Inc (ANAB) Insider Trades Summary
Over the past 18 months, Paul F. Lizzul made 6 insider transaction in AnaptysBio Inc (ANAB) with a net sale of 11,879. Other recent insider transactions involving AnaptysBio Inc (ANAB) include a net sale of 26,687 shares made by Eric J Loumeau , a net sale of 24,965 shares made by Dennis Mulroy , and a net sale of 155,806 shares made by Daniel Faga .
In summary, during the past 3 months, insiders sold 30,440 shares of AnaptysBio Inc (ANAB) in total and bought 273,972 shares, with a net purchase of 243,532 shares. During the past 18 months, 233,237 shares of AnaptysBio Inc (ANAB) were sold and 273,972 shares were bought by its insiders, resulting in a net purchase of 40,735 shares.
AnaptysBio Inc (ANAB)'s detailed insider trading history can be found in Insider Trading Tracker table.
AnaptysBio Inc Insider Transactions
Paul F. Lizzul Mailing Address
Above is the net worth, insider trading, and ownership report for Paul F. Lizzul. You might contact Paul F. Lizzul via mailing address: 30699 Russell Ranch Road, Suite 140, Westlake Village Ca 91362.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
